DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR IONSYS
Clinical Trials for Ionsys
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00665522 | A Prospective Safety Surveillance Study of Fentanyl Iontophoretic Transdermal System (40 Mcg) | Terminated | Alza Corporation, DE, USA | Phase 4 | 2007-12-01 | The purpose of the study is to document the use of fentanyl HCl 40 mcg system under routine conditions and obtain a more comprehensive understanding of the safety of the system and complications that may not be spontaneously reported. |
| NCT00666393 | An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients | Withdrawn | Alza Corporation, DE, USA | Phase 3 | 2008-10-01 | The purpose of this study is to evaluate the safety and clinical utility of fentanyl HCl 40 mcg system for the management of postoperative pain in pediatric inpatients. |
| NCT00708318 | Study Evaluating Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Normal Healthy Subjects | Completed | YM BioSciences | Phase 1 | 2001-10-01 | This was a pilot, phase I, two-period, fasting, bioavailability, safety,and pharmacokinetic study evaluating single dose of i.v. fentanyl (200 µg) and single doses of 2 mL or 3 mL inhaled AeroLEF (500 µg/mL) delivered by nebulization with the AeroEclipse BAN device administered in normal healthy non-smoking subjects. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Ionsys
Condition Name
Clinical Trial Locations for Ionsys
Clinical Trial Progress for Ionsys
Clinical Trial Phase
Clinical Trial Sponsors for Ionsys
Sponsor Name
